Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000097

Director acquired 5,986 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Klein Peter S Director 2022-06-02 Grant or award +5,986 11,313 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Klein Peter S Director 2022-06-02 Grant or award · Stock Option (right to buy) +17,959 17,959 D: show line 2 in the form
Loading xslF345X03/wf-form4_165456056392230.xml…